ARS Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
SPRY
CUSIP
82835W108
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 82835W108 since 12/18/2024, largest first.

Filer % of Class Filed
RA Capital Management, L.P. 13D/A
11.1% 10/1/2025
Event 9/29/2025
Rubric Capital Management LP 13G/A
8.1% 5/15/2026
Event 3/31/2026
James E. Flynn 13D/A
7.8% 8/1/2025
Event 7/30/2025
BlackRock, Inc. 13G 5.3% 7/27/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Millennium Management LLC 13G/A
2.5% 7/14/2026
Event 6/30/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 5 70.8 k $293 k
2026 Q2 219 91.1 M $773 M
2026 Q1 211 94.1 M $757 M
2025 Q4 200 90.2 M $1.05 B
2025 Q3 202 83.7 M $841 M
2025 Q2 199 84.8 M $1.48 B
2025 Q1 194 76.3 M $960 M
2024 Q4 178 71.3 M $752 M
2024 Q3 167 64.1 M $928 M
2024 Q2 127 62.8 M $534 M
2024 Q1 124 60.1 M $615 M
2023 Q4 110 67.3 M $369 M
2023 Q3 109 66.5 M $252 M
2023 Q2 101 55.1 M $369 M
2023 Q1 97 53.4 M $348 M
2022 Q4 77 50.3 M $429 M
2022 Q3 65 30.4 M $160 M
2022 Q2 70 26.1 M $111 M
2022 Q1 72 27.0 M $94.7 M
2021 Q4 76 30.1 M $200 M
2021 Q3 76 28.9 M $288 M
2021 Q2 77 28.0 M $865 M
2021 Q1 69 27.7 M $1.21 B
2020 Q4 64 24.6 M $1.13 B